Stevia Corp. Investor Conference Call - January 29
Post# of 82
Posted On: 02/03/2015 3:15:00 PM
Stevia Corp. Investor Conference Call - January 29, 2015 - (OTCQB: STEV)
INDIANAPOLIS, IN – Stevia Corp. (OTCQB: STEV), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that the company has hosted a conference call on January 29, 2015 at 4:30 PM EST to discuss recent corporate news and its business goals for 2015. We would like to take this opportunity to welcome all our shareholders. To all other interested parties, we hope you find this call interesting and informative.
http://www.steviacorp.com
http://www.realhemp.com
http://www.realhempstore.com
http://www.highcbd.com
Newsletter: http://steviacorp.us9.list-manage.com/subscri...d1081eeb91
---
PRESS RELEASES:
Stevia Corp. Confirms Protocol to Produce Synthetic CBD: http://www.marketwired.com/press-release/stev...978979.htm
Stevia Corp. Appoints Dr. Jerry Smartt to Board of Directors and Welcomes Veteran Research Scientist to Advisory Board: http://www.marketwired.com/press-release/stev...982099.htm
Stevia Corp. Files Key Provisional Patent Application With the United States Patent and Trademark Office for Cannabidiol (CBD) and Acetaminophen Formulation to Treat Pain: http://www.marketwired.com/press-release/stev...983143.htm
Stevia Corp. Files Second Key Provisional Patent Application with the United States Patent and Trademark Office for a Cannabidiol (CBD) and Ibuprofen Formulation to Treat Pain: http://www.prnewswire.com/news-releases/stevi...22756.html
Stevia Corp. Provides Spring Harvest Guidance: http://www.marketwired.com/press-release/stev...986876.htm
Stevia Corp. Files Two Additional Provisional Patent Applications With the United States Patent and Trademark Office for a Cannabidiol (CBD) and Aspirin Formulation and a Cannabidiol and Naproxen Formulation to Treat Pain and Cardiovascular Disease: http://www.marketwired.com/press-release/stev...987034.htm
INDIANAPOLIS, IN – Stevia Corp. (OTCQB: STEV), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that the company has hosted a conference call on January 29, 2015 at 4:30 PM EST to discuss recent corporate news and its business goals for 2015. We would like to take this opportunity to welcome all our shareholders. To all other interested parties, we hope you find this call interesting and informative.
http://www.steviacorp.com
http://www.realhemp.com
http://www.realhempstore.com
http://www.highcbd.com
Newsletter: http://steviacorp.us9.list-manage.com/subscri...d1081eeb91
---
PRESS RELEASES:
Stevia Corp. Confirms Protocol to Produce Synthetic CBD: http://www.marketwired.com/press-release/stev...978979.htm
Stevia Corp. Appoints Dr. Jerry Smartt to Board of Directors and Welcomes Veteran Research Scientist to Advisory Board: http://www.marketwired.com/press-release/stev...982099.htm
Stevia Corp. Files Key Provisional Patent Application With the United States Patent and Trademark Office for Cannabidiol (CBD) and Acetaminophen Formulation to Treat Pain: http://www.marketwired.com/press-release/stev...983143.htm
Stevia Corp. Files Second Key Provisional Patent Application with the United States Patent and Trademark Office for a Cannabidiol (CBD) and Ibuprofen Formulation to Treat Pain: http://www.prnewswire.com/news-releases/stevi...22756.html
Stevia Corp. Provides Spring Harvest Guidance: http://www.marketwired.com/press-release/stev...986876.htm
Stevia Corp. Files Two Additional Provisional Patent Applications With the United States Patent and Trademark Office for a Cannabidiol (CBD) and Aspirin Formulation and a Cannabidiol and Naproxen Formulation to Treat Pain and Cardiovascular Disease: http://www.marketwired.com/press-release/stev...987034.htm
(0)
(0)